CH626263A5 - - Google Patents

Download PDF

Info

Publication number
CH626263A5
CH626263A5 CH831874A CH831874A CH626263A5 CH 626263 A5 CH626263 A5 CH 626263A5 CH 831874 A CH831874 A CH 831874A CH 831874 A CH831874 A CH 831874A CH 626263 A5 CH626263 A5 CH 626263A5
Authority
CH
Switzerland
Prior art keywords
process according
vivo
enzyme
anticoagulant
poison
Prior art date
Application number
CH831874A
Other languages
English (en)
Italian (it)
Inventor
Eraldo Prof Antonini
Original Assignee
Fargal Pharmasint Lab Biochim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fargal Pharmasint Lab Biochim filed Critical Fargal Pharmasint Lab Biochim
Publication of CH626263A5 publication Critical patent/CH626263A5/it

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/48Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482Serine endopeptidases (3.4.21)
    • A61K38/4833Thrombin (3.4.21.5)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/58Reptiles

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
CH831874A 1973-09-03 1974-06-18 CH626263A5 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT5230973 1973-09-03

Publications (1)

Publication Number Publication Date
CH626263A5 true CH626263A5 (fr) 1981-11-13

Family

ID=11276745

Family Applications (1)

Application Number Title Priority Date Filing Date
CH831874A CH626263A5 (fr) 1973-09-03 1974-06-18

Country Status (12)

Country Link
US (1) US4027012A (fr)
JP (1) JPS5637792B2 (fr)
AT (1) AT335614B (fr)
BE (1) BE817699A (fr)
CA (1) CA1028948A (fr)
CH (1) CH626263A5 (fr)
DE (1) DE2428955C3 (fr)
ES (1) ES447851A1 (fr)
FR (1) FR2242110B1 (fr)
GB (1) GB1472574A (fr)
NL (1) NL7407948A (fr)
SE (1) SE420321B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2615844A1 (de) * 1976-04-10 1977-10-20 Knoll Ag Fibrinogen spaltendes enzymsystem
CH626917A5 (fr) * 1976-08-17 1981-12-15 Pentapharm Ag
US4610879A (en) * 1984-01-06 1986-09-09 University Of Southern California Fibrinolytic enzyme from snake vernom
US4849403A (en) * 1985-05-29 1989-07-18 Pentapharm Ag Protein C activator, methods of preparation and use thereof
US5759541A (en) * 1990-07-26 1998-06-02 Basf Aktiengesellschaft Recombinant fibrinogenases, the preparation and use thereof
DE19607210A1 (de) * 1996-02-26 1997-08-28 Knoll Ag Verfahren zur Reinigung von thrombinähnlichen Proteasen aus Schlangengiften
WO2003075936A1 (fr) * 2002-03-11 2003-09-18 Nina Alexandrovna Karagoujova Procede d'elevage des serpents pour obtenir des composants de poison

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1094301A (en) * 1964-02-21 1967-12-06 Nat Res Dev Improvements relating to anticoagulants
FR2011689A1 (fr) * 1968-06-26 1970-03-06 Chugai Slivaku Kk
GB1293795A (en) * 1969-07-04 1972-10-25 Twyford Lab Ltd Improvements relating to anticoagulants
US3743722A (en) * 1971-07-14 1973-07-03 Abbott Lab Anti-coagulant isolation
US3879369A (en) * 1972-05-12 1975-04-22 Abbott Lab Anti-coagulant isolation from malayan pit viper using affinity chromatography
US3819605A (en) * 1973-08-17 1974-06-25 Abbott Lab Anticoagulant isolation from pit viper using a modified agarose bed and eluting with a benzamidine solution

Also Published As

Publication number Publication date
CA1028948A (fr) 1978-04-04
SE420321B (sv) 1981-09-28
NL7407948A (nl) 1975-03-05
FR2242110B1 (fr) 1977-11-04
DE2428955C3 (de) 1979-04-05
GB1472574A (en) 1977-05-04
ATA583374A (de) 1976-07-15
ES447851A1 (es) 1977-07-16
BE817699A (fr) 1974-11-18
FR2242110A1 (fr) 1975-03-28
JPS5049487A (fr) 1975-05-02
JPS5637792B2 (fr) 1981-09-02
SE7407341L (fr) 1975-03-04
DE2428955A1 (de) 1975-03-13
AT335614B (de) 1977-03-25
US4027012A (en) 1977-05-31
DE2428955B2 (de) 1978-08-03

Similar Documents

Publication Publication Date Title
US3842061A (en) Method for isolation of antithrombin from animal tissue materials by adsorption on sulfated carbohydrate gel
Seegers et al. Further studies on the purification of thrombin
US4138287A (en) Purifying and isolating method for hepatitis virus to use in preparing vaccine
CA2024667C (fr) Procede de preparation d'un concentre de complexe de facteur viii de coagulation sanguine et de facteur de willebrnad a partir de plasma total
EP0014333A1 (fr) Procédé de préparation de fibrinogène, complexe de prothrombine contenant les facteurs de coagulation II, VII, IX et X, antithrombine III et solution contenant des sérumprotéines stables au stockage
JPS59155395A (ja) エリスロポエチンの製造方法
Lindblom et al. Identification of the core proteins in proteoglycans synthesized by vascular endothelial cells
US4314994A (en) Process for obtaining a plasminogen activator
CH626263A5 (fr)
CH626917A5 (fr)
US5071961A (en) Method of enrichment of coagulation factors ii, vii, ix and x
DE2711164A1 (de) Antiplasmin und ein antiserum dagegen
Nikkilä Partial purification of clearing factor of postheparin human plasma
CA1283073C (fr) Absorbant et procede pour la purification du facteur viii de coagulation du sang
Olson et al. Adhesion of platelets to purified solid-phase von Willebrand factor: Effects of wall shear rate, ADP, thrombin and ristocetin
TW408129B (en) Method for purifying human urinary thrombomodulin by using hydroxyapatite column
GB2192633A (en) Endotoxin removal
Casillas et al. Chromatographic behaviour of clotting factors
Regnault et al. Affinity purification of human plasma fibronectin on immobilized gelatin
DE3390272C2 (de) Plasminogen-Aktivator, Verfahren zu seiner Herstellung und denselben enthaltendes thrombolytisches Mittel
Ostlund Jr Immunosorbent Chemistry: A Study of Agarose‐Based Column Sorbents for the Removal of Low‐Density Lipoprotein (LDL) from Blood
US4770877A (en) Isolation of a high molecular weight aortic endothelial cell growth inhibitor
CZ290186B6 (cs) Způsob výroby frakce s inaktivovanými viry obsahující faktor VIII chromatografickými metodami a frakce připravitelná tímto způsobem
FI62103C (fi) Foerfarande foer framstaellning av heparin med hoeg specifik aktivitet
CH525251A (de) Verfahren zur Herstellung einer therapeutisch aktiven Aspergillopeptidase zur Verhinderung der Bildung von Blutgerinnseln

Legal Events

Date Code Title Description
PL Patent ceased